A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Removing Transfusion Dependence as a Barrier to Hospice Enrollment
- Status
- COMPLETED
- Phase
- NA
A Study of E7820 in People With Bone Marrow (Myeloid) Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
- Status
- RECRUITING
- Phase
- NA
Inqovi Maintenance Therapy in Myeloid Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)
- Status
- COMPLETED
- Phase
- N/A
Physical Activity in Transfusion Dependent Patients With Myelodysplastic Syndrome
- Status
- WITHDRAWN
- Phase
- N/A
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Status
- RECRUITING
- Phase
- PHASE1
Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)
- Status
- WITHDRAWN
- Phase
- NA
Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1